Tomm Bernklev

5.4k total citations · 1 hit paper
93 papers, 3.8k citations indexed

About

Tomm Bernklev is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Tomm Bernklev has authored 93 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Genetics, 47 papers in Epidemiology and 19 papers in Surgery. Recurrent topics in Tomm Bernklev's work include Microscopic Colitis (46 papers), Inflammatory Bowel Disease (46 papers) and Health Systems, Economic Evaluations, Quality of Life (17 papers). Tomm Bernklev is often cited by papers focused on Microscopic Colitis (46 papers), Inflammatory Bowel Disease (46 papers) and Health Systems, Economic Evaluations, Quality of Life (17 papers). Tomm Bernklev collaborates with scholars based in Norway, Italy and Denmark. Tomm Bernklev's co-authors include Bjørn Moum, Magne Henriksen, Jørgen Jahnsen, Lars‐Petter Jelsness‐Jørgensen, Milada Cvancarova, I. Lygren, Morten H. Vatn, Ole Høie, Inger Camilla Solberg and Morten Vatn and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Tomm Bernklev

93 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)

2008 536 citations Inger Camilla Solberg, Jørgen Jahnsen et al. Scandinavian Journal of Gastroenterology profile →

Peers

Countries citing papers authored by Tomm Bernklev

Since Specialization

Citations

This map shows the geographic impact of Tomm Bernklev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomm Bernklev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomm Bernklev more than expected).

Fields of papers citing papers by Tomm Bernklev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomm Bernklev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomm Bernklev. The network helps show where Tomm Bernklev may publish in the future.

Co-authorship network of co-authors of Tomm Bernklev

This figure shows the co-authorship network connecting the top 25 collaborators of Tomm Bernklev. A scholar is included among the top collaborators of Tomm Bernklev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomm Bernklev. Tomm Bernklev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Thyroidectomy for Euthyroid Patients with Hashimoto Disease and Persistent Symptoms: An Observational, Postrandomization Study 2024 ·Journal of Thyroid Research ·Geir Hoff, Tomm Bernklev, (unknown), (unknown), (unknown), (unknown), Charlotte Gibbs, Tone Hoel Lende, (unknown), (unknown), Roald Omdal, Jan Terje Kvaløy, Håvard Søiland	3
2	Fatigue in Patients with Inflammatory Bowel Disease in Remission One Year After Diagnosis (the IBSEN III Study) 2024 ·Journal of Crohn s and Colitis ·(unknown), Tomm Bernklev, Randi Opheim, (unknown), Trond Espen Detlie, (unknown), Petr Ricanek, ROBERT M. BOYAR, May‐Bente Bengtson, (unknown), (unknown), Svein Oskar Frigstad, (unknown), (unknown), Magne Henriksen, Gert Huppertz‐Hauss, Marte Lie Høivik, Lars‐Petter Jelsness‐Jørgensen	2
3	Health-related quality of life in patients with newly diagnosed inflammatory bowel disease: an observational prospective cohort study (IBSEN III) 2023 ·Quality of Life Research ·(unknown), Randi Opheim, (unknown), Marte Lie Høivik, (unknown), (unknown), (unknown), (unknown), (unknown), May‐Bente Bengtson, Petr Ricanek, Trond Espen Detlie, Tomm Bernklev, Lars‐Petter Jelsness‐Jørgensen, Gert Huppertz‐Hauss	1
4	The multidimensional fatigue inventory (MFI-20): psychometrical testing in a Norwegian sample of inflammatory bowel disease (IBD) patients 2022 ·Scandinavian Journal of Gastroenterology ·Lars‐Petter Jelsness‐Jørgensen, Bjørn Moum, Tore Grimstad, Jørgen Jahnsen, Øistein Hovde, Svein Oskar Frigstad, Tomm Bernklev	5
5	Effect of aerobic exercise intensity on health-related quality of life in severe obesity: a randomized controlled trial 2022 ·Health and Quality of Life Outcomes ·(unknown), Jøran Hjelmesæth, Ronette L. Kolotkin, Øyvind Støren, Solfrid Bratland‐Sanda, Jens Kristoffer Hertel, (unknown), Milada Cvancarova Småstuen, Jan Helgerud, Tomm Bernklev	6
6	Type and Severity of Mental Illness and Participation in Colorectal Cancer Screening 2022 ·American Journal of Preventive Medicine ·(unknown), Paula Berstad, Geir Hoff, Tomm Bernklev, Kristin Ranheim Randel, Øyvind Holme, Thomas de Lange, Kathryn A. Robb, Edoardo Botteri	13
7	Comparing the use of patient-reported outcomes in clinical studies in Europe in 2008 and 2018: a literature review 2021 ·Quality of Life Research ·Guro Lindviksmoen Astrup, Gudrun Rohde, (unknown), Marit Helen Andersen, Tomm Bernklev, Kristin Bjordal, Ragnhild Sørum Falk, (unknown), Knut Stavem, (unknown), Cecilie Delphin Amdal, (unknown)	3
8	Risk of colorectal cancer in a population-based study 20 years after diagnosis of ulcerative colitis: results from the IBSEN study 2020 ·BMJ Open Gastroenterology ·(unknown), Stephan Brackmann, Milada Cvancarova, Marte Lie Høivik, Øistein Hovde, Magne Henriksen, Gert Huppertz‐Hauss, Tomm Bernklev, Ole Høie, (unknown), Inger Camilla Solberg, Njaal Stray, Jørgen Jahnsen, Morten H. Vatn, Bjørn Moum	11
9	Pain Severity and Vitamin D Deficiency in IBD Patients 2019 ·Nutrients ·Svein Oskar Frigstad, Marte Lie Høivik, Jørgen Jahnsen, Milada Cvancarova, Tore Grimstad, Ingrid Prytz Berset, Gert Huppertz‐Hauss, Øistein Hovde, Tomm Bernklev, Bjørn Moum, Lars‐Petter Jelsness‐Jørgensen	13
10	The Impact of Spondyloarthritis and Joint Symptoms on Health-Related Quality of Life and Fatigue in IBD Patients. Results From a Population-Based Inception Cohort (20-Year Follow-up in the Ibsen Study) 2019 ·Inflammatory Bowel Diseases ·(unknown), Øyvind Palm, Milada Cvancarova, Tomm Bernklev, Jørgen Jahnsen, Bjørn Moum, Marte Lie Høivik, (unknown)	15
11	Comparison of the Multiattribute Utility Instruments EQ-5D and SF-6D in a Europe-Wide Population-Based Cohort of Patients with Inflammatory Bowel Disease 10 Years after Diagnosis 2016 ·Gastroenterology Research and Practice ·Gert Huppertz‐Hauss, Eline Aas, Marte Lie Høivik, Ebbe Langholz, Selwyn Odes, Milada Cvancarova Småstuen, Reinhold W. Stockbrügger, Geir Hoff, Bjørn Moum, Tomm Bernklev	8
12	The Use of Complementary and Alternative Medicine among Patients with Inflammatory Bowel Disease Is Associated with Reduced Health-Related Quality of Life 2016 ·Gastroenterology Research and Practice ·Randi Opheim, Marte Lie Høivik, Tomm Bernklev, Lars‐Petter Jelsness‐Jørgensen, Bjørn Moum	10
13	Vitamin D deficiency in inflammatory bowel disease: prevalence and predictors in a Norwegian outpatient population 2016 ·Scandinavian Journal of Gastroenterology ·Svein Oskar Frigstad, Marte Lie Høivik, Jørgen Jahnsen, Sandra Rinne Dahl, Milada Cvancarova, Tore Grimstad, Ingrid Prytz Berset, Gert Huppertz‐Hauss, Øistein Hovde, Roald Torp, Tomm Bernklev, Bjørn Moum, Lars‐Petter Jelsness‐Jørgensen	81
14	Favorable lifestyle before diagnosis associated with lower risk of screen-detected advanced colorectal neoplasia 2016 ·World Journal of Gastroenterology ·Markus Dines Knudsen, Thomas de Lange, Edoardo Botteri, (unknown), (unknown), Chloé B. Steen, Geir Hoff, Tomm Bernklev, Anette Hjartåker, Paula Berstad	22
15	Pain may be an important factor to consider in inflammatory bowel disease patients troubled by fatigue 2016 ·United European Gastroenterology Journal ·Lars‐Petter Jelsness‐Jørgensen, (unknown), Bjørn Moum, Tore Grimstad, Randi Opheim, Jørgen Jahnsen, Tomm Bernklev	9
16	Do no harm: no psychological harm from colorectal cancer screening 2016 ·British Journal of Cancer ·(unknown), Paula Berstad, Edoardo Botteri, (unknown), (unknown), Thomas de Lange, Geir Hoff, Tomm Bernklev	25
17	Patients’ perceptions of quality of care and follow-up in inflammatory bowel disease 2015 ·Scandinavian Journal of Gastroenterology ·Lars‐Petter Jelsness‐Jørgensen, Tomm Bernklev, Øistein Hovde, Ingrid Prytz Berset, Gert Huppertz‐Hauss, Bjørn Moum, Marte Lie Høivik	16
18	Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study 2012 ·Gut ·Marte Lie Høivik, Bjørn Moum, Inger Camilla Solberg, Magne Henriksen, Milada Cvancarova, Tomm Bernklev, (unknown)	202
19	Measuring health‐related quality of life in non‐complicated diabetes patients may be an effective parameter to assess patients at risk of a more serious disease course: a cross‐sectional study of two diabetes outpatient groups 2011 ·Journal of Clinical Nursing ·Lars‐Petter Jelsness‐Jørgensen, Lis Ribu, Tomm Bernklev, Bjørn Moum	8
20	The Role of Quality of Care in Health-related Quality of Life in Patients with IBD 2004 ·Inflammatory Bowel Diseases ·Ingrid van der Eijk, Ioannis G. Vlachonikolis, Pia Munkholm, (unknown), Tomm Bernklev, Pierluigi Politi, Selwyn Odes, Epameinondas V. Tsianos, Reinhold W. Stockbrügger, Maurice G. Rüssel	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact